serw-MX  [xml]  
 


    
 DeCS Categories

C05 Musculoskeletal Diseases .
C05.116 Bone Diseases .
C05.116.198 Bone Diseases, Metabolic .
C05.116.198.371 Mucolipidoses .
C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.163 Brain Diseases, Metabolic .
C10.228.140.163.100 Brain Diseases, Metabolic, Inborn .
C10.228.140.163.100.435 Lysosomal Storage Diseases, Nervous System .
C10.228.140.163.100.435.590 Mucolipidoses .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.565 Metabolism, Inborn Errors .
C16.320.565.189 Brain Diseases, Metabolic, Inborn .
C16.320.565.189.435 Lysosomal Storage Diseases, Nervous System .
C16.320.565.189.435.590 Mucolipidoses .
C16.320.565.202 Carbohydrate Metabolism, Inborn Errors .
C16.320.565.202.670 Mucolipidoses .
C16.320.565.595 Lysosomal Storage Diseases .
C16.320.565.595.554 Lysosomal Storage Diseases, Nervous System .
C16.320.565.595.554.590 Mucolipidoses .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.132 Brain Diseases, Metabolic .
C18.452.132.100 Brain Diseases, Metabolic, Inborn .
C18.452.132.100.435 Lysosomal Storage Diseases, Nervous System .
C18.452.132.100.435.590 Mucolipidoses .
C18.452.648 Metabolism, Inborn Errors .
C18.452.648.189 Brain Diseases, Metabolic, Inborn .
C18.452.648.189.435 Lysosomal Storage Diseases, Nervous System .
C18.452.648.189.435.590 Mucolipidoses .
C18.452.648.202 Carbohydrate Metabolism, Inborn Errors .
C18.452.648.202.670 Mucolipidoses .
C18.452.648.595 Lysosomal Storage Diseases .
C18.452.648.595.554 Lysosomal Storage Diseases, Nervous System .
C18.452.648.595.554.590 Mucolipidoses .
D09 Carbohydrates .
D09.400 Glycoconjugates .
D09.400.500 Lipopolysaccharides .
D09.698 Polysaccharides .
D09.698.357 Fungal Polysaccharides .
D09.698.373 Glycosaminoglycans .
D09.698.718 Polysaccharides, Bacterial .
D09.698.718.450 Lipopolysaccharides .
D10 Lipids .
D10.494 Lipopolysaccharides .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.395 Glycoproteins .
D12.776.395.550 Membrane Glycoproteins .
D12.776.395.550.448 GPI-Linked Proteins .
D12.776.395.550.448.100 Lipopolysaccharide Receptors .
D12.776.543 Membrane Proteins .
D12.776.543.484 Lipid-Linked Proteins .
D12.776.543.484.500 GPI-Linked Proteins .
D12.776.543.484.500.100 Lipopolysaccharide Receptors .
D12.776.543.550 Membrane Glycoproteins .
D12.776.543.550.418 GPI-Linked Proteins .
D12.776.543.550.418.100 Lipopolysaccharide Receptors .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.705 Receptors, Immunologic .
D12.776.543.750.705.045 Lipopolysaccharide Receptors .
D23 Biological Factors .
D23.050 Antigens .
D23.050.161 Antigens, Bacterial .
D23.050.161.616 Polysaccharides, Bacterial .
D23.050.161.616.525 Lipopolysaccharides .
D23.050.202 Antigens, Fungal .
D23.050.202.283 Fungal Polysaccharides .
D23.050.301 Antigens, Surface .
D23.050.301.264 Antigens, Differentiation .
D23.050.301.264.900 Antigens, Differentiation, Myelomonocytic .
D23.050.301.264.900.045 Lipopolysaccharide Receptors .
D23.101 Biomarkers .
D23.101.100 Antigens, Differentiation .
D23.101.100.900 Antigens, Differentiation, Myelomonocytic .
D23.101.100.900.045 Lipopolysaccharide Receptors .
D23.946 Toxins, Biological .
D23.946.123 Bacterial Toxins .
D23.946.123.329 Endotoxins .
D23.946.123.329.500 Lipopolysaccharides .
G02 Chemical Phenomena .
G02.111 Biochemical Phenomena .
G02.111.534 Lipolysis .
G03 Metabolism .
G03.458 Lipid Metabolism .
G03.458.500 Lipolysis .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Lipopolysaccharides .
Lipoglycans .
Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) .
1.00
19868798
 
Lipopolysaccharide Receptors .
CD14 Antigen .
CD14 Monocyte Differentiation Antigen .
LPS Receptor .
Lipoglycan Receptor .
Receptor, LPS .
Receptor, Lipoglycan .
Antigens, CD14 .
CD14 Antigens .
Receptors, Lipopolysaccharide .
Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including MONOCYTES; MACROPHAGES; and some GRANULOCYTES. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein. .
0.82
56150
 
Mucolipidoses .
Cherry Red Spot-Myoclonus Syndrome .
Deficiency Disease, Ganglioside Sialidase .
Glycoprotein Neuraminidase Deficiency .
Inclusion Cell Disease .
Mucolipidosis I .
Mucolipidosis II .
Mucolipidosis III .
Mucolipidosis III Alpha Beta .
Mucolipidosis IIIa .
Mucolipidosis IV .
Mucolipidosis Type 1 .
Mucolipidosis Type I .
Mucolipidosis Type II .
Mucolipidosis Type III .
Mucolipidosis Type IV .
Myoclonus-Cherry Red Spot Syndrome .
Psuedo-Hurler Disease .
Sialolipidosis .
Type I Mucolipidosis .
Type II Mucolipidosis .
Type III Mucolipidosis .
Type IV Mucolipidosis .
Deficiencies, Glycoprotein Neuraminidase .
Deficiency, Glycoprotein Neuraminidase .
Glycoprotein Neuraminidase Deficiencies .
I Cell Disease .
I-Cell Diseases .
Inclusion Cell Diseases .
Lipomucopolysaccharidoses .
Mucolipidoses, Type I .
Mucolipidoses, Type II .
Mucolipidoses, Type III .
Mucolipidoses, Type IV .
Mucolipidosis, Type I .
Mucolipidosis, Type II .
Mucolipidosis, Type III .
Mucolipidosis, Type IV .
Polydystrophy, Pseudo-Hurler .
Pseudo Hurler Polydystrophy .
Psuedo Hurler Disease .
Psuedo-Hurler Diseases .
Sialidoses .
Sialolipidoses .
Type I Mucolipidoses .
Type II Mucolipidoses .
Type III Mucolipidoses .
Type IV Mucolipidoses .
I-Cell Disease .
Lipomucopolysaccharidosis .
Pseudo-Hurler Polydystrophy .
Cherry Red Spot Myoclonus Syndrome .
Ganglioside Sialidase Deficiency Disease .
Mucolipidosis .
Myoclonus Cherry Red Spot Syndrome .
Sialidosis .
A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7) .
0.75
11967
 
Polysaccharides .
Glycans .
0.72
20334019
 
Glycosaminoglycans .
Mucopolysaccharides .
Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). .
0.67
18221610
 
Lipolysis .
Lipolyses .
The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues. .
0.58
616639
 
Fungal Polysaccharides .
Polysaccharides, Fungal .
Cell wall components constituting a polysaccharide core found in fungi. They may act as antigens or structural substrates. .
0.58
5382